ANTI-CD73 ANTIBODY AND USE THEREOF

NOVEL PEPTIDES

ANTI-LRRC15 ANTIBODIES AND USES THEREOF

Antigen Binding Proteins

ANTI-CD73 ANTIBODIES, CONJUGATES, AND METHODS OF USE

CDCP1 ANTIBODIES AND ANTIBODY DRUG CONJUGATES

ANTI-CLDN6 ANTIBODIES AND USE THEREOF

FULLY HUMAN MONOCLONAL ANTIBODIES AGAINST HUMAN HER-2

ANTIBODY CONSTRUCTS FOR DLL3 AND CD3

COMPOUNDS AND METHODS TARGETING INTERLEUKIN-34

CD138/SYNDECAN1 ANTIBODIES AND METHODS OF USE THEREOF

ANTI-LEWIS Y ANTIBODY AND PRO-ANTIBODY THEREOF

BINDING MOLECULES SPECIFIC FOR FCGAMMA RIIA AND USES THEREOF

FULLY HUMAN MONOCLONAL ANTIBODIES AGAINST HUMAN HER-2 AND METHODS FOR USING THE SAME

ANTl-5T4 ANTIGEN BINDING DOMAINS, ANTIBODY-DRUG CONJUGATES AND METHODS OF USE THEREOF

ANTI-B7H3 ANTIBODIES AND METHODS OF USE

NOVEL ANTI-CD3EPSILON ANTIBODIES

PD-1 BNDING PROTEINS, VEGF AND PD-1 BISPECIFIC BINDING PROTEINS, COMPOSITIONS, AND METHODS OF USE

ZIP12 ANTIBODY

CLAUDIN18 ANTIBODIES AND METHODS OF TREATING CANCER

HUMAN CD163 ANTIBODIES AND USES THEREOF

TREATMENT OF CANCER USING CHIMERIC ANTIGEN RECEPTOR

ANTIBODIES TARGETING C-KIT AND/OR SIGLEC AND USES THEREOF

GLYCOENGINEERED POLYPEPTIDES TARGETING ANTI-NEUTROPHIL AUTOANTIBODIES AND USES THEREOF

FLT3 LIGAND BI-FUNCTIONAL MOLECULES FOR THROMBOPENIA AND ACUTE RADIATION SYNDROME

BISPECIFIC ANTIBODIES AND CONSTRUCTS FOR LYSOSOMAL TARGETING DEGRADATION AND METHODS OF USE THEREOF

GLYCOENGINEERED POLYPEPTIDES TARGETING IMMUNOGLOBULIN A AND COMPLEXES COMPRISING THE SAME

ANTI-MESOTHELIN ANTIBODY CONJUGATES AND METHODS OF USE THEREOF

ANTIBODIES TO CD70

LYSOSOMAL DEGRADATION

ANTI-TUMOR ANTIBODIES

HER3 BINDING PROTEIN AND USE THEREOF

HUMAN MONOCLONAL ANTIBODIES TO FUCOSYL-GM1 AND METHODS FOR USING ANTI-FUCOSYL-GM1 ANTIBODIES

ANTIBODIES SPECIFICALLY BINDING TO CEACAM5

ANTI-ROR1 ANTIBODY AND USE THEREOF

RECOMBINANT HUMANIZED MONOCLONAL ANTIBODY TARGETING HUMAN GPRC5D AND APPLICATION THEREOF

MONOCLONAL ANTIBODIES SPECIFIC FOR FIBROBLAST GROWTH FACTOR RECEPTOR 4 (FGFR4) AND METHODS OF THEIR USE

DEGRADATION OF cMET USING A BISPECIFIC BINDING AGENT

ANTI-ROR1 ANTIBODY, BISPECIFIC ANTIBODY COMPRISING SAME, AND USES THEREOF

RECEPTOR-MEDIATED ENDOCYTOSIS FOR TARGETED INTERNALIZATION AND DEGRADATION OF MEMBRANE PROTEINS AND CARGOS

DOSAGES OF IMMUNOCONJUGATES OF ANTIBODIES AND SN-38 FOR IMPROVED EFFICACY AND DECREASED TOXICITY

5T4-BINDING PROTEINS

METHODS OF TREATING DISEASE USING ANTI-IL1RAP ANTIBODIES AND ANTIBODY DRUG CONJUGATES

ANTI-NECTIN-4 ANTIBODY, AND ANTIBODY-DRUG CONJUGATE AND USE THEREOF

ANTI-SCUBE1 ANTIBODY HAVING HIGH INTERNALIZATION CAPACITY IN LEUKEMIA

MEDICAMENTS, USES AND METHODS

ANTI-FGFR3 ANTIBODY CONJUGATE AND MEDICAL USE THEREOF

MUC1 Antibodies and Methods of Use

ANTI-CD63 ANTIBODIES, CONJUGATES, AND USES THEREOF

NANOBODY AND NANOBODY-DRUG CONJUGATE TARGETING CD73, METHOD FOR PREPARING SAME, AND USE THEREOF

ANTI-EGFR/MET ANTIBODIES AND USES THEREOF

ANTIBODY OR FRAGMENT THEREOF THAT BINDS TO FCRL1

EGFR AND C-MET BISPECIFIC BINDING AGENTS, CONJUGATES THEREOF AND METHODS OF USING THE SAME

Binding Proteins 1

ANTI-IL1RAP ANTIBODIES AND COMPOSITIONS

PHARMACEUTICAL COMPOSITION FOR CANCER TREATMENT AND/OR PREVENTION

ANTI-CEACAM5 ANTIBODIES AND USES THEREOF

COMBINATION THERAPY USING AN ANTI-FUCOSYL-GM1 ANTIBODY AND AN ANTI-CD137 ANTIBODY

MUSCLE TARGETING COMPLEXES AND USES THEREOF FOR TREATING DYSTROPHINOPATHIES

LRRC-15-BINDING PROTEIN CONSTRUCTS AND USES THEREOF

ANTI-BDCA2 ANTIBODY AND USE THEREOF

Methods of Treating IL1RAP Associated Cancers with Anti Human Interleukin-1 Receptor Accessory Protein (IL1 RAP) Antibodies

ANTIBODY CONSTRUCTS FOR DLL3 AND CD3

MACROPINOCYTOSING HUMAN ANTI-CD46 ANTIBODIES AND TARGETED CANCER THERAPEUTICS

5T4 BINDING AGENTS AND USES THEREOF

ANTI-LY6H ANTIBODIES AND ANTIBODY DRUG CONJUGATES

Anti-B7H3 antibody and Uses thereof

ANTI-B7-H3 ANTIBODIES AND USES THEREOF

ANTIBODY-DRUG CONJUGATES AND USES THEREOF

ANTIBODY SEQUENCES OF THREE ANTIBODY CANDIDATES TARGETING HUMAN LYMPHOCYTE ANTIGEN 6 FAMILY MEMBER K (LY6K)

MUSCLE TARGETING COMPLEXES AND USES THEREOF FOR TREATING DYSTROPHINOPATHIES

Anti-B7-H4 Antibodies and Immunoconjugates

MULTIFUNCTIONAL MOLECULES BINDING TO TCR AND USES THEREOF

NECTIN-4 BINDING AGENTS

INHIBITING MAST CELL ACTIVATION BY BINDING SIALIC ACID-BINDING IMMUNOGLOBULIN-LIKE LECTIN-9 (SIGLEC-9)

SLITRK6 BINDING AGENTS, CONJUGATES THEREOF AND METHODS OF USING THE SAME

ROR1-SPECIFIC ANTIGEN BINDING MOLECULES

ZIP12 ANTIBODY

METHODS OF TREATING NEUROLOGICAL DISEASES

ANTIBODIES SPECIFIC TO PD-1 AND METHODS OF USE

TIM-3-TARGETING ANTIBODIES AND USES THEREOF

ANTI-NAPI2B ANTIBODIES AND METHODS OF USE

ANTIBODIES AGAINST CLAUDIN-6 AND USES THEREOF

Monoclonal Antibodies Against CLDN18.2 and Fc-Engineered Versions Thereof

A GROUP OF B7H3 MONOCLONAL ANTIBODIES AND MEDICAL USE THEREOF

CD98HC ANTIGEN-BINDING DOMAINS AND USES THEREFOR

TRANSFERRIN RECEPTOR ANTIGEN-BINDING DOMAINS AND USES THEREFOR

NOVEL METHODS OF THERAPY

ANTI-HUMAN B7-H3 ANTIBODY AND APPLICATION THEREOF

Cation-Independent Mannose-6-Phosphate Receptor Binders

METHODS AND SYSTEMS FOR IDENTIFYING OR TREATING CENTRAL NERVOUS SYSTEMS DISEASE

METHODS TO MANIPULATE ALPHA-FETOPROTEIN (AFP)

Monoclonal Antibodies Against CLDN18.2 and Fc-Engineered Versions Thereof

ANTI-TROP2 ANTIBODY-DRUG CONJUGATE

ANTI-ROR1 ANTIBODIES

THERAPEUTIC ANTIBODIES

ANTIBODIES TARGETING SIRP-ALPHA AND USES THEREOF

SIL-6R AND CTGF BINDING PROTEINS AND METHODS OF USE THEREOF

MUSCLE TARGETING COMPLEXES AND USES THEREOF FOR TREATING DYSTROPHINOPATHIES

ANTI-PSMA ANTIBODIES, VARIANTS, AND USES THEREOF

ANTI-DLL3 ANTIBODY

Antibodies That Bind Human Cannabinoid 1 (CB1) Receptor

POLYNUCLEOTIDES ENCODING ANTIBODIES WHICH BIND THE EC3 DOMAIN OF CADHERIN-6 (CDH6) AND POSSESS INTERNALIZATION ABILITY

ANTIBODY VARIANTS AND USES THEREOF

ANTI-SERUM ALBUMIN NANOBODY AND DERIVATIVE THEREOF

BISPECIFIC ANTIBODIES AND METHODS OF USE

TREM2 STABILIZING ANTIBODIES

MONOVALENT ANTI-TREM2 BINDING MOLECULES AND METHODS OF USE THEREOF

ISOFORM-SELECTIVE TGFB1 INHIBITORS AND USE THEREOF

ANTI-COLLAGEN TRIPLE HELIX REPEAT CONTAINING 1 (CTHRC1) ANTIBODIES AND METHODS OF USING THE SAME

CONJUGATES FOR TREATING INFLAMMATORY DISEASE AND IDENTIFICATION OF PATIENTS LIKELY TO BENEFIT FROM SUCH TREATMENT

BINDING MOLECULES SPECIFIC TO HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2

ANTI-TROPHOBLAST CELL SURFACE ANTIGEN 2 (TROP-2) ANTIBODIES

Anti-CD40 Antibodies for Use in Treatment of Sjogren's Syndrome

ANTI-ADENOSINE RECEPTOR (A2aR) ANTIBODIES AND THE USE THEREOF

ANTI-CD94 ANTIBODIES AND METHODS OF USE THEREOF

COMPOSITIONS AND METHODS FOR INTERNALIZING ENZYMES

MUSCLE TARGETING COMPLEXES AND USES THEREOF FOR TREATING DYSTROPHINOPATHIES

ANTI-CEACAM5 ANTIBODIES AND CONJUGATES AND USES THEREOF

MUSCLE TARGETING COMPLEXES AND USES THEREOF FOR TREATING DYSTROPHINOPATHIES

ROR1-TARGETED BINDING MOLECULE AND USE THEREOF

COMPOSITIONS AND METHODS OF TREATING LUPUS NEPHRITIS

HUMANIZED COMPLEMENT 5A RECEPTOR 1 ANTIBODIES AND METHODS OF USE THEREOF

ANTI-PROGRAMMED DEATH-LIGAND 1 (PD-L1) ANTIBODIES

Methods of Bone Marrow Conditioning

COMPOSITIONS AND METHODS FOR INTERNALIZING ENZYMES

MUSCLE TARGETING COMPLEXES AND USES THEREOF FOR TREATING DYSTROPHINOPATHIES

CONJUGATED ANTIBODIES AGAINST LY75 FOR THE TREATMENT OF CANCER

ANTI-IL-13RA2 MONOCLONAL ANTIBODIES AND USES THEREOF

ANTI-RAGE ANTIBODY

MUSCLE TARGETING COMPLEXES AND USES THEREOF FOR TREATING DYSTROPHINOPATHIES

HUMAN IGG1 FC REGION VARIANTS AND USES THEREOF

ANTI- PROGRAMMED DEATH-LIGAND 1 (PD-L1) ANTIBODY MOLECULES, ENCODING POLYNUCLEOTIDES, AND METHODS OF USE

HERV-K ANTIBODY, CELL, VACCINE, AND DRUG THERAPEUTICS

Anti-SIRP-Alpha Antibodies and Methods of Use Thereof

TREM2 STABILIZING ANTIBODIES

Method of modulating autoimmunity by disrupting cis-ligand binding of siglec type antigens

ANTIBODIES BINDING CLDN18.2 AND USES THEREOF

DUAL SPECIFICITY ANTIBODIES TO PD-L1 AND PD-L2 AND METHODS OF USE THEREFOR

CELL-SURFACE ANTIBODY TO A SPECIFIC BIOMARKER OF PANCREATIC BETA-CELLS

BISPECIFIC ANTIGEN BINDING CONSTRUCTS TARGETING HER2

ANTIBODY VARIANTS

METHOD OF TREATING OR AMELIORATING METABOLIC DISORDERS USING GLP-1 RECEPTOR AGONISTS CONJUGATED TO ANTAGONISTS FOR GASTRIC INHIBITORY PEPTIDE RECEPTOR (GIPR)

BISPECIFIC ANTIBODY AGAINST ALPHA-SYN/IGF1R AND USE THEREOF

NANOPARTICLE PLATFORM FOR ANTIBODY AND VACCINE DELIVERY

ANTIBODIES AND ANTIBODY-DRUG CONJUGATES TARGETING CLAUDIN 6

CHIMERIC POLYPEPTIDE COMPOSITIONS AND ENCODING POLYNUCLEOTIDES THEREOF

HIGH AFFINITY HUMAN AND MONKEY SPECIFIC TFR-1 VNARS

ANTI-NKG2A ANTIBODIES AND USES THEREOF

COMPOUNDS AND METHODS TARGETING EPIREGULIN

ANTIBODY-PEPTIDE FUSION PROTEINS FOR TREATING AMYLOID DISORDERS

BAFF-R TARGETED CHIMERIC ANTIGEN RECEPTOR-MODIFIED T-CELLS AND USES THEREOF

HUMANIZED ANTI-CCR7 RECEPTOR ANTIBODIES

COMPOSITIONS AND METHODS FOR THE MODULATION OF BETA CHAIN-MEDIATED IMMUNITY

ANTI-ILT3 ANTIBODIES AND ANTIBODY DRUG CONJUGATES

Anti-TREM1 Antibodies and Methods of Use Thereof

ANTI-CDH6 ANTIBODIES AND ANTIBODY-DRUG CONJUGATES THEREOF

METHODS OF USING BISPECIFIC ANTIGEN-BINDING CONSTRUCTS TARGETING HER2

THERAPEUTIC BINDING MOLECULES

ANTIBODIES TARGETING CDH19 FOR MELANOMA

ANTI-HSP70 ANTIBODIES AND THERAPEUTIC USES THEREOF

ANTIBODIES AGAINST LYPD3

BISPECIFIC BINDING PROTEINS AND USES THEREOF

BISPECIFIC ANTIBODIES AGAINST HER2

ANTI-CD70 ANTIBODIES, CONJUGATES THEREOF AND METHODS OF USING THE SAME

MONOCLONAL ANTIBODIES AGAINST HER2 EPITOPE AND METHODS OF USE THEREOF

ROR1 ANTIBODIES

LIPOSOME ENCAPSULATED AFFINITY DRUG

ASGR INHIBITORS

Antibody Variants

NOVEL FLT3 ANTIBODIES AND ANTIBODY-DRUG-CONJUGATES BASED THEREON, THERAPEUTIC METHODS AND USES THEREOF IN COMBINATION WITH TYROSINE KINASE INHIBITORS

ANTIBODY-DRUG CONJUGATE

ANTIBODY VARIANTS AND USES THEREOF

ANTIBODIES TO ANTI-SIGLEC-9 AND MULTISPECIFIC ANTIBODIES TARGETING SIGLEC-7 AND SIGLEC-9

DLK1 ANTIBODIES AND METHODS OF TREATING CANCER

ANTI-CD39 ANTIBODIES, COMPOSITIONS COMPRISING ANTI-CD39 ANTIBODIES AND METHODS OF USING ANTI-CD39 ANTIBODIES

HER3 ANTIGEN-BINDING MOLECULES

ANTI-CCR8 AGENTS

ANTI-NECTIN-4-ANTIBODIES AND USES THEREOF

TARGETING TUMOR CELLS WITH CHEMOTHERAPEUTIC AGENTS CONJUGATED TO MATRIPTASE ANTIBODIES

CANCER SPECIFIC PLECTIN-1 SPECIFIC ANTIBODIES AND METHODS OF USE THEREOF

Humanized complement 5A receptor 1 antibodies and methods of use thereof

CLAUDIN 18.2-BINDING ANTIBODIES AND FRAGMENTS THEREOF

ANTI-TMEFF1 ANTIBODIES AND ANTIBODY DRUG CONJUGATES

HUMANIZED ANTI-CD19 ANTIBODIES AND THEIR USE IN TREATMENT OF ONCOLOGY, TRANSPLANTATION AND AUTOIMMUNE DISEASE

WEEKLY DOSING REGIMENS FOR ANTI-CD30 VC-PAB-MMAE ANTIBODY DRUG-CONJUGATES

Antibodies Reactive with B7-H3, Immunologically Active Fragments Thereof and Uses Thereof

ANTI-CLDN18.2 ANTIBODY AND USE THEREOF

EGFRVIII-TARGETED COMPOUNDS AND USES THEREOF

Muscle targeting complexes and uses thereof for treating dystrophinopathies

ANTI-B7-H3 ANTIBODY AND APPLICATION THEREOF

NOVEL ANTI-CD276 ANTIBODIES AND THE USES THEREOF

Muscle targeting complexes and uses thereof for treating dystrophinopathies

ANTIBODY-DRUG CONJUGATE CONJUGATED VIA BREAKABLE LINKER

Humanized complement 5a receptor 1 antibodies and methods of use thereof

TREATMENT WITH ANTI-KIR3DL2 AGENTS

ANTIBODIES AGAINST CLEAVED CDCP1 AND USES THEREOF

D3-BINDING MOLECULES AND USES THEREOF

MONOCLONAL ANTIBODIES TARGETING ACETYLATED TAU AND METHODS OF USE THEREOF

MUSCLE TARGETING COMPLEXES AND USES THEREOF FOR TREATING DYSTROPHINOPATHIES

GRP78-BINDING ANTIBODIES AND USE THEREOF IN DETECTING OR NEUTRALIZING GRP78

HUMANIZED ANTIBODIES THAT BIND LGR5

ANTIBODY MOLECULES AND CONJUGATES

CELL-PENETRATING DEGRADING ANTIBODY THAT PENETRATES INTO CELLS TO DEGRADE AND REMOVE TARGET PROTEIN AND USE THEREOF

Antibody-drug conjugates and uses thereof

COMPOSITIONS, DOSES, AND METHODS FOR TREATMENT OF THYROID EYE DISEASE

ANTIBODIES AND MOLECULES THAT IMMUNOSPECIFICALLY BIND TO BTN1A1 AND THE THERAPEUTIC USES THEREOF

ANTIBODY VARIANTS

Glycan-Interacting Compounds and Methods of Use

NOVEL CLDN 18.2-SPECIFIC MONOCLONAL ANTIBODIES AND METHODS OF USE THEREOF

BINDING AGENTS TARGETING TROP2-EXPRESSING TUMOR CELLS

Cation-Independent Mannose-6-Phosphate Receptor Binders For Targeted Protein Degradation

HIF-1a INHIBITOR

MUSCLE TARGETING COMPLEXES AND USES THEREOF FOR TREATING DYSTROPHINOPATHIES

Binding agents targeting TROP2-expressing tumor cells

BINDING AGENTS TARGETING TROP2-EXPRESSING TUMOR CELLS

Epithelial Cadherin-Specific Antibodies

ANTI-CADM1 ANTIBODY

Antibodies and antibody-drug conjugates targeting claudin 6

METHODS OF TREATING NEUROLOGICAL DISEASES

RADIOLABELED MET BINDING PROTEINS FOR IMMUNO-PET IMAGING

ADAPTER POLYPEPTIDES AND METHODS OF USING THE SAME

BCMA Monoclonal Antibody-Drug Conjugate

HUMAN ANTIBODY DRUG CONJUGATES AGAINST TISSUE FACTOR

ANTI-HLA-DQ2.5/8 ANTIBODY AND ITS USE FOR THE TREATMENT OF CELIAC DISEASE

ANTI-CD300F ANTIBODY AND USES THEREOF

Muscle-targeting complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide and methods of use thereof to target dystrophin and to treat Duchenne muscular dystrophy

BAFF-R ANTIBODIES AND USES THEREOF

BINDING MOLECULES SPECIFIC FOR FCGAMMA RIIA AND USES THEREOF

BISPECIFIC MOLECULE SPECIFICALLY BINDING TO B7-H3 AND TGFB AND USES THEREOF

COMPOSITIONS AND METHODS FOR TREATING AGE-RELATED DISEASES

COMPOSITIONS AND METHODS FOR DELIVERY OF NUCLEIC ACIDS TO CELLS

COMPOSITIONS AND METHODS FOR DELIVERY OF NUCLEIC ACIDS TO CELLS

BIFUNCTIONAL COMPOUNDS CONTAINING IGF-2 POLYPEPTIDES

ANTI-TIM3 ANTIBODIES AND METHODS OF USE

Anti-CD45 antibodies and conjugates thereof

CELL-PENETRATING ANTI-DNA ANTIBODIES AND USES THEREOF INHIBIT DNA REPAIR

HIGHLY SPECIFIC RABBIT SINGLE -DOMAIN ANTIBODIES FOR DRUG DELIVERY IN IMMUNOTHERAPY APPLICATIONS

NOVEL ANTI-TPBG ANTIBODY AND ANTIBODY-DRUG-CONJUGATES BASED THEREON, THERAPEUTIC METHODS AND USES THEREOF

HUMAN CD163 ANTIBODIES AND USES THEREOF

ANTIBODY CONJUGATE COMPRISING ANTI-P-CADHERIN ANTIBODY AND USES THEREOF

Muscle targeting complexes and uses thereof for treating myotonic dystrophy

COMBINATION THERAPY USING AN ANTI-FUCOSYL-GM1 ANTIBODY AND AN ANTI-CD137 ANTIBODY

ANTIBODIES TARGETING FLT3 AND USE THEREOF

Improved immunoglobulin II

HETERODIMERIC ANTIBODY FC-CONTAINING PROTEINS AND METHODS FOR PRODUCTION THEREOF

COMPOSITIONS AND METHODS FOR DELIVERING THERAPEUTIC POLYNUCLEOTIDES

ANTI-NECTIN-4 ANTIBODY AMANITIN CONJUGATES

ANTI-TIM-3 ANTIBODIES AND METHODS OF USE THEREOF

HUMANIZED ANTI-CA IX ANTIBODIES AND METHODS OF THEIR USE

COMPOSITIONS AND METHODS FOR INCREASING TRANSPORT INTO THE BRAIN

WEEKLY DOSING REGIMENS FOR ANTI-CD30 VC-PAB-MMAE ANTIBODY DRUG-CONJUGATES

COMBINATION THERAPY USING AN ANTI-FUCOSYL-GM1 ANTIBODY AND AN ANTI-CD137 ANTIBODY

ANTIBODIES TARGETING FLT3 AND USE THEREOF

ANTIGEN-BINDING MOLECULES WITH IMPROVED CYTOSOL-PENETRATING ACTIVITY

ANTI-CD73 MONOCLONAL ANTIBODIES

PEPTIDES

SITE-SPECIFIC GLYCOENGINEERING OF TARGETING MOIETIES

ANTI-CD71 ACTIVATABLE ANTIBODY DRUG CONJUGATES AND METHODS OF USE THEREOF

Immunomodulatory antibodies and methods of use thereof

ANTI-MET ANTIBODIES AND USES THEREOF

ANTI-FGFR3 ANTIBODY AND USE THEREOF

BISPECIFIC ANTIBODIES COMPRISING AN NRP1 BINDING DOMAIN AND METHODS OF USE THEREOF

High-Affinity Mycobacterium Tuberculosis Capsule-Specific Human Monoclonal Antibody

ANTIBODY-DRUG CONJUGATE LYOPHILISED FORMULATION

ANTIBODIES BINDING AXL

Antibody-drug conjugate

Anti-SIRP-alpha antibodies and methods of use thereof

ENGINEERED ANTIBODIES AND USES THEREOF

ANTI-STEM CELL FACTOR ANTIBODIES AND METHODS OF BLOCKING THE INTERACTION BETWEEN SCF AND c-KIT

ANTI-PD-L1 ANTIBODIES AND FUSION PROTEINS THEREOF

Muscle targeting complexes and uses thereof for treating facioscapulohumeral muscular dystrophy

Muscle targeting complexes and uses thereof for treating dystrophinopathies

SITE-SPECIFIC GLYCOENGINEERING OF TARGETING MOIETIES

COMPOSITIONS AND METHODS OF TREATING LUPUS NEPHRITIS

ANTI-HER3 ANTIBODY AND ANTI-HER3 ANTIBODY-DRUG CONJUGATE AND MEDICAL USE THEREOF

INTERNALIZING HUMAN MONOCLONAL ANTIBODIES TARGETING PROSTATE CANCER CELLS IN SITU

Type-II VNAR polypeptides which bind human TfR-1, encoding nucleic acids thereof and method of use thereof

NPC1 MONOBODIES AND MONOBODY CONJUGATES THEREOF

METHODS OF USING ANTIBODIES RECOGNIZING TAU

Antibody Constructs for CDH19 and CD3

HUMAN ANTIBODIES TO TN ANTIGEN

Bifunctional Molecules for Lysosomal Targeting and Related Compositions and Methods

Antibody-peptide fusion proteins for treating amyloid disorders

Binding proteins 1

THERAPEUTIC MOLECULES

ERIBULIN-BASED ANTIBODY-DRUG CONJUGATES AND METHODS OF USE

MULTIVALENT MEDITOPES, MEDITOPE-BINDING ANTIBODIES AND USES THEREOF

Anti-CD46 antibodies and methods of use

NUCLEIC ACIDS ENCODING HUMAN ANTIBODIES TO SIALYL-LEWIS A

TIM-3-targeting antibodies and uses thereof

Materials And Methods For Binding Siglec-3/CD33

Materials And Methods For Binding Siglec-3/CD33

ANTI-CD22 ANTIBODY MOLECULE OR ANTIGEN-BINDING FRAGMENT AND USE THEREOF

Antibodies That Bind Human Cannabinoid 1 (CB1) Receptor

Therapeutic antibodies against ROR-1 protein and methods for use of same

BINDING MOLECULES SPECIFIC FOR CD73 AND USES THEREOF

OPTIMIZED ANTIBODIES THAT TARGET CD19

Antibodies Directed Against CD127

Muscle targeting complexes and uses thereof for treating facioscapulohumeral muscular dystrophy